Investigation of FOXM1 as a potential new target for melanoma
A Miyashita, S Fukushima, S Nakahara, J Yamashita… - PloS one, 2015 - journals.plos.org
Recent studies have shown that immunotherapies and molecular targeted therapies are
effective for advanced melanoma. Non-antigen-specific immunotherapies such as …
effective for advanced melanoma. Non-antigen-specific immunotherapies such as …
Etlingera elatior Extract promotes cell death in B16 melanoma cells via down-regulation of ERK and Akt signaling pathways
A Krajarng, M Chulasiri, R Watanapokasin - BMC complementary and …, 2017 - Springer
Abstract Background Torch ginger (Etlingera elatior, EE) is a ginger plant that found in
Southeast Asia. Previous study showed its flowers and leaves composed of several …
Southeast Asia. Previous study showed its flowers and leaves composed of several …
IQ motif containing GTPase activating proteins (IQGAPs), A-kinase anchoring proteins (AKAPs) and kinase suppressor of ras proteins (KSRs) in scaffolding oncogenic …
T Mohapatra, M Dixit - ACS omega, 2022 - ACS Publications
Scaffolding proteins colocalize interacting partners on their surface and facilitate complex
formation. They have multiple domains and motifs, which provide binding sites for various …
formation. They have multiple domains and motifs, which provide binding sites for various …
miR-410-3p is induced by vemurafenib via ER stress and contributes to resistance to BRAF inhibitor in melanoma
Despite significant development of melanoma therapies, death rates remain high.
MicroRNAs, controlling posttranscriptionally gene expression, play role in development of …
MicroRNAs, controlling posttranscriptionally gene expression, play role in development of …
Bioinformatics analysis of rheumatoid arthritis tissues identifies genes and potential drugs that are expressed specifically
Q He, H Ding - Scientific Reports, 2023 - nature.com
Studies have implicated necroptosis mechanisms in orthopaedic-related diseases, since
necroptosis is a unique regulatory cell death pattern. However, the role of Necroptosis …
necroptosis is a unique regulatory cell death pattern. However, the role of Necroptosis …
A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC
Mutant KRAS represents one of the most frequently observed oncogenes in NSCLC, yet no
therapies are approved for tumors that express activated KRAS variants. While there is …
therapies are approved for tumors that express activated KRAS variants. While there is …
Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA
Here we present miR-CATCHv2. 0, an implemented experimental method that allows the
identification of the microRNA species directly bound to an RNA of interest. After cross …
identification of the microRNA species directly bound to an RNA of interest. After cross …
Cell cycle‐tailored targeting of metastatic melanoma: Challenges and opportunities
NK Haass, B Gabrielli - Experimental Dermatology, 2017 - Wiley Online Library
The advent of targeted therapies of metastatic melanoma, such as MAPK pathway inhibitors
and immune checkpoint antagonists, has turned dermato‐oncology from the “bad guy” to the …
and immune checkpoint antagonists, has turned dermato‐oncology from the “bad guy” to the …
[HTML][HTML] The anti-apoptotic BAG3 protein is involved in BRAF inhibitor resistance in melanoma cells
BAG3 protein, a member of BAG family of co-chaperones, has a pro-survival role in several
tumour types. BAG3 anti-apoptotic properties rely on its characteristic to bind several …
tumour types. BAG3 anti-apoptotic properties rely on its characteristic to bind several …
Electrotransfer of plasmid DNA encoding an anti-mouse endoglin (CD105) shRNA to B16 melanoma tumors with low and high metastatic potential results in …
T Dolinsek, G Sersa, L Prosen, M Bosnjak, M Stimac… - Cancers, 2015 - mdpi.com
Endoglin overexpression is associated with highly proliferative tumor endothelium and also
with some tumors, including melanoma. Its targeting has anti-tumor effectiveness, which can …
with some tumors, including melanoma. Its targeting has anti-tumor effectiveness, which can …